The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Global disparities in SARS-CoV-2 genomic surveillance
Open accessAbstract
Genomic sequencing is essential to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments, vaccines, and guide public health responses. To investigate the global SARS-CoV-2 genomic surveillance, we used sequences shared via GISAID to estimate the impact of sequencing intensity and turnaround times on variant detection in 189 countries. In the first two years of the pandemic, 78% of high-income countries sequenced >0.5% of their COVID-19 cases, while 42% of low- and middle-income countries reached that mark. Around 25% of the genomes from high income countries were submitted within 21 days, a pattern observed in 5% of the genomes from low- and middle-income countries. We found that sequencing around 0.5% of the cases, with a turnaround time <21 days, could provide a benchmark for SARS-CoV-2 genomic surveillance. Socioeconomic inequalities undermine the global pandemic preparedness, and efforts must be made to support low- and middle-income countries improve their local sequencing capacity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Detection of a SARS-CoV-2 variant of concern in South Africa
Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03402-9 · Cited by 2,510
Self-citationData, disease and diplomacy: GISAID's innovative contribution to global health
Elbe, S., & Buckland‐Merrett, G. (2017) · Global Challenges · doi:10.1002/gch2.1018 · Cited by 1,928
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Viana, R., Moyo, S., Amoako, D. G., Tegally, H., Scheepers, C., Althaus, C. L., Anyaneji, U. J., Bester, P. A., Boni, M. F., Chand, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04411-y · Cited by 1,690
Self-citationAssessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D. D. S., Mishra, S., Crispim, M. A. E., Sales, F. C. S., Hawryluk, I., McCrone, J. T., et al. (2021) · Science · doi:10.1126/science.abh2644 · Cited by 1,461
Self-citationTowards a genomics-informed, real-time, global pathogen surveillance system
Gardy, J. L., & Loman, N. J. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.88 · Cited by 771
Brister, J. R., Ako-adjei, D., Bao, Y., & Blinkova, O. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1207 · Cited by 649
Genetic Variants of SARS-CoV-2—What Do They Mean?
Lauring, A. S., & Hodcroft, E. B. (2021) · JAMA · doi:10.1001/jama.2020.27124 · Cited by 604
Cited by
Gangavarapu, K., Latif, A. A., Mullen, J. L., Alkuzweny, M., Hufbauer, E., Tsueng, G., Haag, E., Zeller, M., Aceves, C. M., Zaiets, K., et al. (2023) · Nature Methods · doi:10.1038/s41592-023-01769-3 · Cited by 394
Self-citation
Metadata
- Authors
- Brito, A. F., Semenova, E., Dudas, G., Hassler, G. W., Kalinich, C. C., Kraemer, M. U. G., Ho, J., Tegally, H., Githinji, G., Agoti, C. N., Matkin, L. E., Whittaker, C., Bulgarian SARS-CoV-2 sequencing group, Kantardjiev, T., Korsun, N., Stoitsova, S., Dimitrova, R., Trifonova, I., Dobrinov, V., Grigorova, L., Stoykov, I., Grigorova, I., Gancheva, A., Communicable Diseases Genomics Network (Australia and New Zealand), Jennison, A., Leong, L., Speers, D., Baird, R., Cooley, L., Kennedy, K., de Ligt, J., Rawlinson, W., van Hal, S., Williamson, D., COVID-19 Impact Project, Singh, R., Nathaniel-Girdharrie, S., Edghill, L., Indar, L., St. John, J., Gonzalez-Escobar, G., Ramkisoon, V., Brown-Jordan, A., Ramjag, A., Mohammed, N., Foster, J. E., Potter, I., Greenaway-Duberry, S., George, K., Belmar-George, S., Lee, J., Bisasor-McKenzie, J., Astwood, N., Sealey-Thomas, R., Laws, H., Singh, N., Oyinloye, A., McMillan, P., Hinds, A., Nandram, N., Parasram, R., Khan-Mohammed, Z., Charles, S., Andrewin, A., Johnson, D., Keizer-Beache, S., Oura, C., Pybus, O. G., Faria, N. R., Danish Covid-19 Genome Consortium, Stegger, M., Albertsen, M., Fomsgaard, A., Rasmussen, M., Fiocruz COVID-19 Genomic Surveillance Network, Khouri, R., Naveca, F., Graf, T., Miyajima, F., Wallau, G., Motta, F., GISAID core curation team, Khare, S., Freitas, L., Schiavina, C., Bach, G., Schultz, M. B., Chew, Y. H., Makheja, M., Born, P., Calegario, G., Romano, S., Finello, J., Diallo, A., Lee, R. T. C., Xu, Y. N., Yeo, W., Tiruvayipati, S., Yadahalli, S., Network for Genomic Surveillance in South Africa (NGS-SA), Wilkinson, E., Iranzadeh, A., Giandhari, J., Doolabh, D., Pillay, S., Ramphal, U., San, J. E., Msomi, N., Mlisana, K., von Gottberg, A., Walaza, S., Ismail, A., Mohale, T., Engelbrecht, S., Van Zyl, G., Preiser, W., Sigal, A., Hardie, D., Marais, G., Hsiao, M., Korsman, S., Davies, M.-A., Tyers, L., Mudau, I., York, D., Maslo, C., Goedhals, D., Abrahams, S., Laguda-Akingba, O., Alisoltani-Dehkordi, A., Godzik, A., Wibmer, C. K., Martin, D., Lessells, R. J., Bhiman, J. N., Williamson, C., de Oliveira, T., Swiss SARS-CoV-2 Sequencing Consortium, Chen, C., Nadeau, S., du Plessis, L., Beckmann, C., Redondo, M., Kobel, O., Noppen, C., Seidel, S., de Souza, N. S., Beerenwinkel, N., Topolsky, I., Jablonski, P., Fuhrmann, L., Dreifuss, D., Jahn, K., Ferreira, P., Posada-Céspedes, S., Beisel, C., Denes, R., Feldkamp, M., Nissen, I., Santacroce, N., Burcklen, E., Aquino, C., de Gouvea, A. C., Moccia, M. D., Grüter, S., Sykes, T., Opitz, L., White, G., Neff, L., Popovic, D., Patrignani, A., Tracy, J., Schlapbach, R., Dermitzakis, E., Harshman, K., Xenarios, I., Pegeot, H., Cerutti, L., Penet, D., Stadler, T., Howden, B. P., Sintchenko, V., Zuckerman, N. S., Mor, O., Blankenship, H. M., de Oliveira, T., Lin, R. T. P., Siqueira, M. M., Resende, P. C., Vasconcelos, A. T. R., Spilki, F. R., Aguiar, R. S., Alexiev, I., Ivanov, I. N., Philipova, I., Carrington, C. V. F., Sahadeo, N. S. D., Branda, B., Gurry, C., Maurer-Stroh, S., Naidoo, D., von Eije, K. J., Perkins, M. D., van Kerkhove, M., Hill, S. C., Sabino, E. C., Pybus, O. G., Dye, C., Bhatt, S., Flaxman, S., Suchard, M. A., Grubaugh, N. D., Baele, G., & Faria, N. R.
- Venue
- Nature Communications
- Published
- 2022-11-16
- Volume
- 13
- Issue
- 1
- Pages
- 7003-7003
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W4309338001
- Cited by
- 284
- References
- 36
- FWCI
- 25.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global disparities in SARS-CoV-2 genomic surveillance. https://app.cochat.ai/papers/10.1038/s41467-022-33713-y
- The paper
- Brito, A. F., Semenova, E., Dudas, G., Hassler, G. W., Kalinich, C. C., Kraemer, M. U. G., Ho, J., Tegally, H., Githinji, G., Agoti, C. N., Matkin, L. E., Whittaker, C., Bulgarian SARS-CoV-2 sequencing group, Kantardjiev, T., Korsun, N., Stoitsova, S., Dimitrova, R., Trifonova, I., Dobrinov, V., . . . Faria, N. R. (2022). Global disparities in SARS-CoV-2 genomic surveillance. Nature Communications. https://doi.org/10.1038/s41467-022-33713-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.